Additionally, the expression of ASF1B was significantly negatively correlated with immune scores in GBM and UCEC and positively correlated with immune scores in THCA, KIRC, and LGG (Figure 9B; Figure S3). This evidence concerns the gene ASF1B and glioblastoma.